Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease

INTRODUCTION: Unsupervised digital cognitive testing is an appealing means to capture subtle cognitive decline in preclinical Alzheimer's disease (AD). Here, we describe development, feasibility, and validity of the Boston Remote Assessment for Neurocognitive Health (BRANCH) against in‐person c...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp, Kathryn V., Samaroo, Aubryn, Chou, Hsiang‐Chin, Buckley, Rachel, Schneider, Olivia R., Hsieh, Stephanie, Soberanes, Daniel, Quiroz, Yakeel, Properzi, Michael, Schultz, Aaron, García‐Magariño, Iván, Marshall, Gad A., Burke, Jane G., Kumar, Raya, Snyder, Noah, Johnson, Keith, Rentz, Dorene M., Sperling, Reisa A., Amariglio, Rebecca E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cognitive & Behavioral Assessment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481881/
https://www.ncbi.nlm.nih.gov/pubmed/34621977
http://dx.doi.org/10.1002/dad2.12243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481881/
https://www.ncbi.nlm.nih.gov/pubmed/34621977
http://dx.doi.org/10.1002/dad2.12243

Ejemplares similares